Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Buy
47,510
+19,849
+72% +$8.35M 0.02% 447
2026
Q1
$10.4M Buy
27,661
+21,621
+358% +$9.26M 0.01% 726
2025
Q4
$2.58M Buy
6,040
+2,174
+56% +$946K ﹤0.01% 1352
2025
Q3
$1.73M Sell
3,866
-510
-12% -$231K ﹤0.01% 1525
2025
Q2
$2.13M Buy
4,376
+740
+20% +$422K ﹤0.01% 1294
2025
Q1
$2.24M Sell
3,636
-5,278
-59% -$3M ﹤0.01% 1182
2024
Q4
$4.72M Sell
8,914
-274
-3% -$154K 0.01% 820
2024
Q3
$5.52M Sell
9,188
-10
-0.1% -$5.67K 0.01% 745
2024
Q2
$4.99M Sell
9,198
-79
-0.9% -$45.3K 0.01% 722
2024
Q1
$5.96M Buy
9,277
+16
+0.2% +$9.72K 0.01% 666
2023
Q4
$5.42M Buy
9,261
+656
+8% +$367K 0.01% 661
2023
Q3
$4.47M Buy
8,605
+41
+0.5% +$21.3K 0.01% 680
2023
Q2
$4.64M Buy
8,564
+224
+3% +$122K 0.01% 672
2023
Q1
$4.48M Sell
8,340
-682
-8% -$348K 0.01% 669
2022
Q4
$4.61M Sell
9,022
-2
-0% -$974 0.01% 637
2022
Q3
$3.94M Buy
+9,024
New +$4.34M 0.02% 576

Other funds holding CHE

Mariner's CHE Position: Q2 2026 in Review

Mariner increased its Chemed (CHE) stake by 72% in Q2 2026, buying an estimated $8.35M and bringing the position to 47,510 shares worth $22.1M. The position accounts for 0.02% of the portfolio, ranked #447.

Mariner first reported a position in CHE in Q3 2022 and has held it in 16 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Mariner held 47,510 shares of Chemed worth $22.1M as of Q2 2026.
  • Mariner bought 19,849 Chemed shares in Q2 2026, an estimated $8.35M.
  • Chemed made up 0.02% of Mariner's portfolio in Q2 2026, its #447 holding.
  • Mariner first reported a position in Chemed in Q3 2022 and has held it in 16 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.